Home › Waldenstrom Macroglobulinemia › New York › Queens
Waldenstrom Macroglobulinemia clinical trials in Queens, NY
4 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RecruitingPhase 1
- Optum Medical Care PC, Westbury · 14 mi away
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
Recruiting
- Northwell (Northshore University/Long Island Jewish Hospitals), New Hyde Park · 9 mi away
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- New York City, NY6 studies
- Edison, NJ6 studies
- Dallas, TX6 studies
- Houston, TX6 studies
- Seattle, WA5 studies
- Rochester, MN5 studies
- Milwaukee, WI5 studies
- Columbus, OH4 studies
- Baldwin Park, CA4 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.